Sequential Multiple Assignment Treatment for Bipolar Disorder
Completed · Phase 4
Conditions studied: Bipolar I Disorder, Bipolar II Disorder
In brief
The purpose of this study is to compare which of the two mood stabilizers (drugs that help to steady/stabilize mood in patients with bipolar disorder (BD)), lithium and divalproex, is more effective in patients with bipolar disorder over 26 weeks. The study will also compare if lithium or divalproex used alone versus lithium or divalproex used with quetiapine versus lithium or divalproex used with lamotrigine is more effective when symptoms of depression develop.
Key facts
- Study ID
- NCT01588457
- Run by
- The University of Texas Health Science Center at San Antonio
- People needed
- 112
- Starts
- 2011-06-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2020-08-19
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- DSM-IV TR (Diagnostic and Statistical Manual Edition IV Text Revision) diagnosis BD I or II as assessed by MINI PLUS (Mini International Neuropsychiatric Interview PLUS)
- Male or female ≥ 18 years old
- Currently symptomatic with a CGI-BP-S ≥3 for mania/hypomania \&/or depression for ≥ 2 weeks
- One of the following indicators of recent active illness: a depressive or manic or hypomanic or mixed episode in the past 12 months
- If female of child bearing age must use effective birth control.
You may not qualify if…
- Unwilling or unable to comply with study requirements
- Renal impairment (serum creatinine > 1.5 mg/dL)
- If maintained on thyroid medication must be euthyroid for at least 1 month before Visit 1
- Patients who have had intolerable side effects to QTP, Li, Div, or LTG
- Patients whose clinical status requires inpatient care
- Drug/alcohol dependence within the past 30 days
- Pregnancy as determined by serum pregnancy test or breastfeeding
- History of poor response to Li at a serum Li of ≥ 0.5 mEq/L (milliequivalents per Liter) or Div at a serum level of ≥ 45 mg/dL for at least 2 weeks.
Where it is running
- Case Western Reserve University — Cleveland, Ohio, United States
- University of Texas Health Science Center — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.